Glenn W. Welling - Engaged Capital 13F Activity & Position Changes (Q3 2018)

According to the SEC 13F filed on Aug 14, 2026, the Engaged Capital portfolio showed several notable changes in holdings as of quarter-end Sep 30, 2018. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q3 2018, the filing reported:

New Buys - Anika Therapeutics Inc., Astec Industries, Inc., Puma Biotechnology Inc

Increases - Benchmark Electronics, Inc., NCR Voyix Corporation

Reductions - Universal Electronics Inc., Upbound Group, Inc.

Complete Exits - Caseys General Stores, Inc., Cross Country Healthcare, Inc.

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q3 2018	ANIK Anika Therapeutics Inc.	Anika Therapeutics Inc.	Buy - Position Entry	+386,926	-	$16.32K	386,926
Q3 2018	ASTE Astec Industries, Inc.	Astec Industries, Inc.	Buy - Position Entry	+73,605	-	$3.71K	73,605
Q3 2018	BHE Benchmark Electronics, Inc.	Benchmark Electronics, Inc.	Buy	+901,913	+66.0%	$53.09K	2,268,787
Q3 2018	CASY Caseys General Stores, Inc.	Caseys General Stores, Inc.	Sell - Position Exit	-36,672	-100.0%	$0.00	-
Q3 2018	CCRN Cross Country Healthcare, Inc.	Cross Country Healthcare, Inc.	Sell - Position Exit	-207,680	-100.0%	$0.00	-
Q3 2018	PBYI Puma Biotechnology Inc	Puma Biotechnology Inc	Buy - Position Entry	+151,689	-	$6.96K	151,689
Q3 2018	UEIC Universal Electronics Inc.	Universal Electronics Inc.	Sell	-59,866	-23.8%	$7.55K	191,810
Q3 2018	UPBD Upbound Group, Inc.	Upbound Group, Inc.	Sell	-4,450,000	-49.5%	$65.19K	4,533,609
Q3 2018	VYX NCR Voyix Corporation	NCR Voyix Corporation	Buy	+723,264	+203.3%	$30.66K	1,079,063